Using Spatial Biology to Navigate Treatments for Each Cancer Patient - Jana Fischer, Navignostics
Navigating treatments for each cancer patient
Jana Fischer, PhD
Co-Founder and CEO at Navignostics
Navignostics is breaking ground as the first institution to translate spatial insights into the clinic. They are leveraging spatial proteomics with Imaging Mass Cytometry, into actionable reporting within 72 hours of sample receipt, revolutionizing treatment decisions.
#imagingmasscytometry